Paper16645899
Gastric H,K-ATPase as a drug target.
Shin JM and 1 other. Dig Dis Sci, 2006. Cited by 19 papers, by iCite.
Cite this record
ConductScience Library. Gastric H,K-ATPase as a drug target. Papers, record 16645899. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16645899
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Ulcer Agents | Major topic |
| H(+)-K(+)-Exchanging ATPase | Major topic |
| Peptic Ulcer | Major topic |
| Proton Pump Inhibitors | Major topic |
| Enzyme Inhibitors | |
| Gastric Acid | |
| Helicobacter pylori | |
| Humans | |
| Imidazoles | |
| Molecular Structure |
Source PubMed
References86
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15715390 | An endangered species in the stomach. | Sci Am | 2005 | https://conductscience.org/library/papers/15715390 | PubMed |
| 2 | 15882117 | Novel approaches to the pharmacological blockade of gastric acid secretion. | Expert Opin Investig Drugs | 2005 | https://conductscience.org/library/papers/15882117 | PubMed |
| 3 | 15740541 | A comparative study of the early effects of tenatoprazole 40 mg and esomeprazole 40 mg on intragastric pH in healthy volunteers. | Aliment Pharmacol Ther | 2005 | https://conductscience.org/library/papers/15740541 | PubMed |
| 4 | 1655768 | Identification of an extracytoplasmic region of H+,K(+)-ATPase labeled by a K(+)-competitive photoaffinity inhibitor. | J Biol Chem | 1991 | https://conductscience.org/library/papers/1655768 | PubMed |
| 5 | 6095911 | Evidence for acid-induced transformation of omeprazole into an active inhibitor of (H+ + K+)-ATPase within the parietal cell. | Biochim Biophys Acta | 1984 | https://conductscience.org/library/papers/6095911 | PubMed |
| 6 | 12525698 | Modeling of the inhibitory interaction of phospholamban with the Ca2+ ATPase. | Proc Natl Acad Sci U S A | 2003 | https://conductscience.org/library/papers/12525698 | PubMed |
| 7 | 16042660 | Review article: the long-term use of proton-pump inhibitors. | Aliment Pharmacol Ther | 2005 | https://conductscience.org/library/papers/16042660 | PubMed |
| 8 | 2547073 | 2-[[(4-Amino-2-pyridyl)methyl]sulfinyl]benzimidazole H+/K+-ATPase inhibitors. The relationship between pyridine basicity, stability, and activity. | J Med Chem | 1989 | https://conductscience.org/library/papers/2547073 | PubMed |
| 9 | 1316171 | cDNA cloning and membrane topology of the rabbit gastric H+/K(+)-ATPase alpha-subunit. | Biochim Biophys Acta | 1992 | https://conductscience.org/library/papers/1316171 | PubMed |
| 10 | 3026477 | Inhibition of (H+ + K+)-ATPase by omeprazole in isolated gastric vesicles requires proton transport. | Biochim Biophys Acta | 1987 | https://conductscience.org/library/papers/3026477 | PubMed |
| 11 | 3017315 | Structural studies on H+,K+-ATPase: determination of the NH2-terminal amino acid sequence and immunological cross-reactivity with Na+,K+-ATPase. | Biochem Biophys Res Commun | 1986 | https://conductscience.org/library/papers/3017315 | PubMed |
| 12 | 1313110 | (H+,K+)-ATPase inhibiting 2-[(2-pyridylmethyl)sulfinyl]benzimidazoles. 4. A novel series of dimethoxypyridyl-substituted inhibitors with enhanced selectivity. The selection of pantoprazole as a clinical candidate. | J Med Chem | 1992 | https://conductscience.org/library/papers/1313110 | PubMed |
| 13 | 15613615 | Identification of the K efflux channel coupled to the gastric H-K-ATPase during acid secretion. | Physiol Genomics | 2005 | https://conductscience.org/library/papers/15613615 | PubMed |
| 14 | 2168418 | Calcium binding to the H+,K(+)-ATPase. Evidence for a divalent cation site that is occupied during the catalytic cycle. | J Biol Chem | 1990 | https://conductscience.org/library/papers/2168418 | PubMed |
| 15 | 12379118 | SCH28080, a K+-competitive inhibitor of the gastric H,K-ATPase, binds near the M5-6 luminal loop, preventing K+ access to the ion binding domain. | Biochemistry | 2002 | https://conductscience.org/library/papers/12379118 | PubMed |
| 16 | 12563304 | A proton-pump inhibitor expedition: the case histories of omeprazole and esomeprazole. | Nat Rev Drug Discov | 2003 | https://conductscience.org/library/papers/12563304 | PubMed |
| 17 | 23336 | Characterization and development of cimetidine as a histamine H2-receptor antagonist. | Gastroenterology | 1978 | https://conductscience.org/library/papers/23336 | PubMed |
| 18 | 7557078 | Turnover of the gastric H+,K(+)-adenosine triphosphatase alpha subunit and its effect on inhibition of rat gastric acid secretion. | Gastroenterology | 1995 | https://conductscience.org/library/papers/7557078 | PubMed |
| 19 | 9494064 | Differences in pH-dependent activation rates of substituted benzimidazoles and biological in vitro correlates. | Pharmacology | 1998 | https://conductscience.org/library/papers/9494064 | PubMed |
| 20 | 8382947 | Membrane topology and omeprazole labeling of the gastric H+,K(+)-adenosinetriphosphatase. | Biochemistry | 1993 | https://conductscience.org/library/papers/8382947 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 29018343 | Impact of Gastric H+/K+-ATPase rs2733743 on the Intragastric pH-Values of Dexlansoprazole Injection in Chinese Subjects. | Front Pharmacol | 2017 | https://conductscience.org/library/papers/29018343 | PubMed |
| 27784845 | Potassium Channelopathies and Gastrointestinal Ulceration. | Gut Liver | 2016 | https://conductscience.org/library/papers/27784845 | PubMed |
| 26667240 | Computational insights into the interaction mechanism of triazolyl substituted tetrahydrobenzofuran derivatives with H(+),K(+)-ATPase at different pH. | J Comput Aided Mol Des | 2016 | https://conductscience.org/library/papers/26667240 | PubMed |
| 25848696 | ATP4a is required for development and function of the Xenopus mucociliary epidermis - a potential model to study proton pump inhibitor-associated pneumonia. | Dev Biol | 2015 | https://conductscience.org/library/papers/25848696 | PubMed |
| 24845980 | Protonated form: the potent form of potassium-competitive acid blockers. | PLoS One | 2014 | https://conductscience.org/library/papers/24845980 | PubMed |
| 22192310 | A high-throughput scintillation proximity-based assay for human DNA ligase IV. | Assay Drug Dev Technol | 2012 | https://conductscience.org/library/papers/22192310 | PubMed |
| 19640897 | The renal H+-K+-ATPases: physiology, regulation, and structure. | Am J Physiol Renal Physiol | 2010 | https://conductscience.org/library/papers/19640897 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/16645899
GET https://conductscience.org/api/papers/v1/16645899/references?page=2